NCT00086112View on ClinicalTrials.gov

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

PHASE3CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2005

Conditions
Anxiety Disorders
Interventions
DRUG

risperidone oral tablets

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00086112 - Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy. | Biotech Hunter | Biotech Hunter